These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22715548)

  • 1. Pioglitazone safe, so save.
    Banerjee S
    J Assoc Physicians India; 2012 Jan; 60():62-6. PubMed ID: 22715548
    [No Abstract]   [Full Text] [Related]  

  • 2. Pioglitazone and bladder cancer: the pros and cons.
    Panikar V
    J Assoc Physicians India; 2012 Jan; 60():72-3. PubMed ID: 22715550
    [No Abstract]   [Full Text] [Related]  

  • 3. Pioglitazone: beyond glucose control.
    de Pablos-Velasco P
    Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1057-67. PubMed ID: 20670183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone--where do we stand in India?
    Mohan V; Bedi S; Unnikrishnan R; Sahay BK; Joshpi S; Misra A
    J Assoc Physicians India; 2012 Jan; 60():68-70. PubMed ID: 22715549
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical efficacy of Pioglitazone (AD-4833)].
    Kaneko T; Baba S
    Nihon Rinsho; 1997 Nov; 55 Suppl():142-6. PubMed ID: 9434458
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thiazolidindiones in type II diabetes mellitus].
    Bornkessel B
    Med Monatsschr Pharm; 1998 Mar; 21(3):66-8. PubMed ID: 9556974
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective modulation of PPARĪ³ activity can lower plasma glucose without typical thiazolidinedione side-effects in patients with Type 2 diabetes.
    Dunn FL; Higgins LS; Fredrickson J; DePaoli AM;
    J Diabetes Complications; 2011; 25(3):151-8. PubMed ID: 20739195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
    Teranishi T; Ohara T; Maeda K; Zenibayashi M; Kouyama K; Hirota Y; Kawamitsu H; Fujii M; Sugimura K; Kasuga M
    Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study comparing the effect of pioglitazone in combination with either metformin or sulphonylureas on lipid profile and glycaemic control in patients with type 2 diabetes (ECLA).
    Karamanos B; Thanopoulou A; Drossinos V; Charalampidou E; Sourmeli S; Archimandritis A;
    Curr Med Res Opin; 2011 Feb; 27(2):303-13. PubMed ID: 21142615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal of pioglitazone in patients with type 2 diabetes mellitus.
    Iwase M; Asano T; Sasaki N; Yoshizumi H; Hiramatsu S; Sakai Y; Ogo A; Iida M
    J Clin Pharm Ther; 2010 Aug; 35(4):401-8. PubMed ID: 20831543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed-dose combination therapy for type 2 diabetes: sitagliptin plus pioglitazone.
    Bailey CJ; Green BD; Flatt PR
    Expert Opin Investig Drugs; 2010 Aug; 19(8):1017-25. PubMed ID: 20629618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of pioglitazone to stable insulin therapy in patients with poorly controlled type 2 diabetes: results of a double-blind, multicentre, randomized study.
    Davidson JA; Perez A; Zhang J;
    Diabetes Obes Metab; 2006 Mar; 8(2):164-74. PubMed ID: 16448520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
    Charbonnel BH; Matthews DR; Schernthaner G; Hanefeld M; Brunetti P;
    Diabet Med; 2005 Apr; 22(4):399-405. PubMed ID: 15787663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone/glimepiride (Duetact) for diabetes.
    Med Lett Drugs Ther; 2007 Jan; 49(1253):9-11. PubMed ID: 17261966
    [No Abstract]   [Full Text] [Related]  

  • 15. [Against insulin resistance. Insulin sensitizers].
    Verspohl EJ; Weiland F
    Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
    [No Abstract]   [Full Text] [Related]  

  • 16. Rational choice of oral antihyperglycaemic agents.
    Chowdhury S; Sengupta N
    J Indian Med Assoc; 2002 Mar; 100(3):174-5, 177. PubMed ID: 12408278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes drug safety update: Avandia and your heart.
    Johns Hopkins Med Lett Health After 50; 2010 Jun; 22(4):1-2, 7. PubMed ID: 20572316
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rosiglitazone (BRL-49653)].
    Oka Y
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():438-41. PubMed ID: 12387030
    [No Abstract]   [Full Text] [Related]  

  • 19. Pioglitazone/metformin (Actoplus met).
    Med Lett Drugs Ther; 2006 Jan; 48(1227):9-11. PubMed ID: 16444136
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.